Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksGLS
resources
GLS

Alivus Life Sciences Ltd.

NSE: ALIVUS
BSE: 543322
Sector: Healthcare
Industry: Pharmaceuticals
1,269.00+13.4 (+1.07%)
22 Oct, 12:00 AM

Annual Reports and Financial Documents

Alivus Life Sciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Alivus Life Sciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Analyst / Investor Meet22 Oct 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Please find enclosed herewith details of Earnings Call slated for Friday, October 30, 2026.
  2. Closure of Trading Window21 Oct 2026
    Closure of Trading Window
    Intimation of closure of trading window from 1st October, 2026 to 31st October, 2026 (both days inclusive), for the purpose of approval of unaudited financial results for the quarter and ....
  3. Board Meeting21 Oct 2026
    Board Meeting Intimation for Inter-Alia, Considering And Approving Unaudited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September, 2026.
    Alivus Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Unaudited Financial ....
  4. General9 Oct 2026
    Announcement Under Regulation 30 Of SEBI (LODR), 2015
    Kindly refer the attachment.
  5. General7 Oct 2026
    Announcement Under Regulation 30 Of SEBI (LODR), 2015 - Acquisition.
    We would like to inform that the Company has acquired 9.21% stake in Torrent Urja 19 Private Limited.
  6. General16 Sept 2026
    The Company Has Incorporated A Wholly Owned Subsidiary Company In Brazil.
    Please find enclosed herewith intimation with respect to incorporation of wholly owned subsidiary of the Company in Brazil.
  7. Analyst / Investor Meet11 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Enclosed please find herewith details of Investor meet.
  8. AGM8 Sept 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Please find attached herewith Scrutinizer''s Report.
  9. AGM8 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Please find attached herewith proceedings of the 15th Annual General Meeting of Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) held on 8th September, 2026.
  10. Analyst / Investor Meet7 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Enclosed please find herewith details of Investor meet.
  11. Analyst / Investor Meet5 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Enclosed please find herewith Investor meet details.
  12. Analyst / Investor Meet25 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meetings
  13. Press Release / Media Release18 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Enclosed please find herewith Press Release with respect to Acquisition.
  14. Acquisition18 Aug 2026
    Announcement under Regulation 30 (LODR)-Acquisition
    Enclosed please find herewith intimation pursuant to Regulation 30 of SEBI (LODR), 2015 with respect to acquisition.
  15. Analyst / Investor Meet13 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting
  16. Newspaper Publication13 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find enclosed herewith Newspaper Advertisement of Notice of 15th Annual General Meeting and E-Voting information.
  17. Business Responsibility and Sustainability Reporting (BRSR)11 Aug 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Please find enclosed herewith the Business Responsibility & Sustainability Report for FY 2025-26
  18. Reg. 34 (1) Annual Report11 Aug 2026
    Reg. 34 (1) Annual Report.
    Please find enclosed herewith Integrated Annual Report FY 2025-26 under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  19. AGM11 Aug 2026
    Notice Of 15Th Annual General Meeting Of The Company For FY 2025-26 As Required Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
    Please find attached herewith Notice convening the 15th Annual General Meeting.
  20. Analyst / Investor Meet7 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Enclosed please find herewith details of investor meet.

Frequently Asked Questions

Where can I download the annual report of Alivus Life Sciences Ltd.?
Annual reports of Alivus Life Sciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Alivus Life Sciences Ltd.?
Quarterly earnings results and presentations of Alivus Life Sciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Alivus Life Sciences Ltd. publish earnings call transcripts?
Earnings call transcripts of Alivus Life Sciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Alivus Life Sciences Ltd.?
Investor presentations and annual day presentations of Alivus Life Sciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Alivus Life Sciences Ltd.?
Corporate announcements and regulatory filings of Alivus Life Sciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Alivus Life Sciences Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Alivus Life Sciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Alivus Life Sciences Ltd.?
The ISIN (International Securities Identification Number) of Alivus Life Sciences Ltd. is INE03Q201024. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Alivus Life Sciences Ltd. listed?
Alivus Life Sciences Ltd. is listed on NSE and BSE. The NSE symbol is GLS and the BSE code is -.
Where can I find the shareholding pattern of Alivus Life Sciences Ltd.?
The quarterly shareholding pattern of Alivus Life Sciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Alivus Life Sciences Ltd. on Sharpely?
Share price data for Alivus Life Sciences Ltd. is updated as of 22 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.